Changes in the vaccine advisory process in the United States have disrupted immunization guidance, which reinforces the need for independent evidence review to inform decisions regarding immunization ...
U.S. automakers are trimming their outlook for electric vehicles amid lingering consumer doubts, a pullback in federal support and a challenging economic landscape that is affecting all auto sales. On ...
GM's $1.6 billion charge linked to EV capacity adjustments GM may incur further charges due to capacity reassessment Automaker expects EV adoption to slow Oct 14 (Reuters) - General Motors (GM.N), ...
The Nimbus variant, or NB.1.8.1, is a strain of SARS-CoV-2, which causes COVID-19. Alongside the usual symptoms of COVID-19, it can cause a razor blade sensation in the throat and gastrointestinal ...
At current emission rates, we're just over three years away from blowing through the remaining carbon budget to limit warming to 1.5°C. This new international study paints a stark picture: the pace of ...
June 24 (Reuters) - The Gates Foundation said on Tuesday it will commit $1.6 billion over the next five years to support Gavi, a public-private partnership that helps buy vaccines for the world's ...
A new COVID variant is spreading quite quickly and is under monitoring by the WHO. The new is variant called NB.1.8.1 and is in the same family as Omicron. Here's what to look out for and potential ...
Linus Torvalds officially announced the stable release of the Linux kernel 6.15 on May 25, 2025. Its arrival was delayed for a few hours, Torvalds said, "because of a last-minute bug report resulting ...
Paul Dodds has received funding from the UK government through the Climate Services for a Net Zero World (CS-N0W) programme. While the UK government set the research questions for the study, it was ...
Tirzepatide and semaglutide are highly effective medications for obesity management. The efficacy and safety of tirzepatide as compared with semaglutide in adults with obesity but without type 2 ...
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...
A daily GLP-1 pill can help people with type 2 diabetes regulate their blood sugar and lose weight, drugmaker Eli Lilly announced on Thursday. The readout comes just days after Pfizer announced it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback